Musculoskeletal disorders

About The Musculoskeletal Disorders Research Advisory Group

Musculoskeletal (MSK) disorders are conditions which involve joints, bone, ligaments, muscles, nerves or tendons, which together make up the MSK system. Many of these conditions cause pain and limited mobility, which can have a significant impact on quality of life. More research in these areas is urgently needed to help improve the lives of people living with MSK conditions.

The Musculoskeletal Disorders Research Advisory Group works to improve the quality and impact of research which seeks to develop our understanding and management of musculoskeletal conditions.

Conditions this group cover include, but are not limited to:

This group aims to be inclusive of all musculoskeletal disorders except those already included by the Autoimmune Disorders and Inflammatory Arthritis Research Advisory Groups.

Accepting MSK conditions as a part of life is not acceptable. The Musculoskeletal Disorders Research Advisory Group first met in July 2019 and seeks to link patients, researchers, and healthcare professionals with funders or other agencies who influence the funding and research strategy of musculoskeletal conditions. With this group, we hope to communicate the importance, priority and need for research into MSK disorders with other organisations that fund or influence MSK research.

More research in this area could lead to a better understanding of these conditions, as well as new and improved ways to manage and treat them. This will improve the quality of life of people living with MSK disorders.

Take part in our research prioritisation exercise

The Musculoskeletal Disorders Research Advisory Group Versus Arthritis is carrying out an online research prioritisation exercise. In this second part of the exercise, we’re seeking opinions on the top priorities for musculoskeletal disorders research. We want to hear from you if you are, or care for, a person living with a musculoskeletal condition, a researcher, a healthcare professional, an industry representative, a research funder, a healthcare provider or government policy maker.

Part 1 of our research prioritisation exercise was completed between November 2020 – January 2021. From peoples’ responses to our first survey, we produced a list of research areas into musculoskeletal conditions. By deciding what are the most important areas for you will help us to identify, shape and champion the areas of research to better understand and manage musculoskeletal conditions. This is a critical part of planned work by the Musculoskeletal Disorders Research Advisory Group Versus Arthritis throughout 2020 and 2021.

The survey is now live and will remain open until 5pm on 28 September 2021 and should take no more than 40 minutes to complete.

Ethics Approval Reference: R71769/RE003 (Medical Sciences Interdivisional Research Ethics Committee, University of Oxford).

Group Lead – Dr Fiona Watt

Dr Fiona Watt is a consultant rheumatologist and researcher whose clinical and research interests include osteoarthritis, painful common musculoskeletal conditions and the effects of injury on the joint.

She is based at Imperial College London, and is a member of two Versus Arthritis centres of excellence: the Centre for Osteoarthritis Pathogenesis and the Centre for Sport, Exercise and Osteoarthritis.

In May 2019 Fiona was awarded the prestigious UKRI Future Leaders Fellowship. This will allow her to further her research into better treatments for people living with and at risk of developing osteoarthritis after injury.

Group membership

  • Dr Fiona Watt. University Research Lecturer, Honorary Consultant Rheumatologist, University of Oxford
  • Colin Wilkinson. Patient Insight Partner Versus Arthritis
  • Amanda Clark. Patient Insight Partner Versus Arthritis
  • Deborah Dulake. Patient Insight Partner Versus Arthritis
  • Jane Taylor-Wormald. Patient Insight Partner Versus Arthritis
  • Professor Richard Jones. Professor of Clinical Biomechanics, University of Salford
  • Professor Ruth Wilcox. Professor of Biomedical Engineering, University of Leeds
  • Dr Stephen Richardson. Senior Lecturer, Division of Cell Matrix Biology & Regenerative Medicine, The University of Manchester
  • Professor Christine Le Maitre. Professor of Cell Biology and Tissue Regeneration, Sheffield Hallam University
  • Professor John Loughlin. Professor of Musculoskeletal Research, Newcastle University
  • Professor Hemant Pandit. Professor of Orthopaedics and Honorary Consultant, University of Leeds and Leeds Teaching Hospitals NHS Trust
  • Professor George Peat. Professor of Clinical Epidemiology, Keele University
  • Dr Linda Troeberg. Senior Lecturer, University of East Anglia
  • Dr David Andersson. Senior Lecturer, King's College London
  • Dr Debbie Mason. Reader, School of Biosciences; Director of Pre-Clinical Research - Cardiff University
  • Dr Christopher Brown. Lecturer of Psychological Sciences, University of Liverpool
  • Dr Neal Millar. Clinical Senior Lecturer (Immunology) - University of Glasgow
  • Dr Emma Clark. Reader in Rheumatology, University of Bristol
  • Dr Zoe Paskins. Senior Lecturer, Honorary Consultant Rheumatologist, Keele University
  • Dr Emma Salt. Consultant Physiotherapist, University Hospitals of Derby and Burton NHS Foundation Trust
  • Dr Felicity Bishop. Associate Professor (Psychology), University of Southampton
  • Dr Elspeth Wise. GP, South Shields (Newcastle)
  • Dr Maura McCarron. Rheumatologist, Belfast Health and Social Care Trust
  • Dr Tim Barlow. Trainee orthopaedic surgeon, University Hospitals Coventry and Warwickshire NHS Trust
  • Malvika Gulati. D Phil student, University of Oxford (maternity leave)

Paediatric Rheumatology Clinical Study Group Representative

Victoria Harbottle, Paediatric Physiotherapist- Great North Children's Hospital, Newcastle Upon Tyne.